Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112919033 | 11291903 | 3 | F | 2014 | 20160718 | 20150722 | 20160726 | EXP | PR-ABBVIE-15K-131-1428856-00 | ABBVIE | 43.72 | YR | F | Y | 68.10000 | KG | 20160726 | CN | COUNTRY NOT SPECIFIED | PR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112919033 | 11291903 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | N | 1054632 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | |||||
112919033 | 11291903 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | N | 1054632 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112919033 | 11291903 | 1 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112919033 | 11291903 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112919033 | 11291903 | Intestinal obstruction | |
112919033 | 11291903 | Osteoporosis | |
112919033 | 11291903 | Post procedural complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112919033 | 11291903 | 1 | 20141127 | 2015 | 0 | |
112919033 | 11291903 | 2 | 2015 | 2016 | 0 |